(Reuters) - "There's no change regarding GE Healthcare's strategy," Graeme Holland, a spokesman for GE Healthcare, which is based outside London, said on Thursday.
"We remain committed to our vision of 'early health' and will continue to evaluate in-vitro diagnostics opportunities that fit our early health strategy, pursuing growth through organic and inorganic means."
Read more at Reuters.com Mergers News
"We remain committed to our vision of 'early health' and will continue to evaluate in-vitro diagnostics opportunities that fit our early health strategy, pursuing growth through organic and inorganic means."
Read more at Reuters.com Mergers News
No comments:
Post a Comment